Delta 9 Cannabis (NINE) Stock Price, News & Analysis

Company Overview

Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers. It also owns and operates retail cannabis store in Winnipeg, Manitoba, as well as cannabis superstore in Brandon, Manitoba. The company operates its retail stores under the Delta 9 Cannabis Store brand name. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.

Key Stats

• Today's Range: C$1.03 to C$1.13
• 50-Day Range: C$1.03 to C$1.03
• 52-Week Range: C$0.92 to C$2.35
• Volume: 68,728 shs
• Average Volume: 117,300 shs
• Market Capitalization: C$89.36 million
• P/E Ratio: 19.07
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NINE Stock Analysis - Frequently Asked Questions

How have NINE shares performed this year?

Delta 9 Cannabis' stock was trading at C$1.03 on January 1st, 2025. Since then, NINE stock has increased by 0.0% and is now trading at C$1.03.

How do I buy shares of Delta 9 Cannabis?

Shares of NINE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Delta 9 Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Delta 9 Cannabis investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Bank of America (BAC), Cannabis Wheaton Income (CBWTF), Emerald Health Therapeutics (EMH), Meta Platforms (META) and TELUS (T).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: CVE:NINE
• CIK: N/A
• Web: www.delta9.ca
• Phone: 855-245-1259
• Fax: N/A
• Employees: 940
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 19.07
• Forward P/E Ratio: 5.42
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 33.00
• Current Ratio: 4.44
• Quick Ratio: 2.04

Sales & Book Value

• Annual Sales: C$12.87 million
• Price / Sales: 6.94
• Cash Flow: C$0.09 per share
• Price / Cash Flow: 11.91
• Book Value: C$0.53 per share
• Price / Book: 1.95

Miscellaneous

• Outstanding Shares: 86,760,000
• Free Float: N/A
• Market Cap: C$89.36 million
• Optionable: Not Optionable
• Beta: N/A